Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.848 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8462 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8452 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8235 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8208 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8144 |
Intermediate Similarity |
NPD1512 |
Approved |
0.809 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8034 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8023 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7976 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD919 |
Approved |
0.7919 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7874 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.787 |
Intermediate Similarity |
NPD2533 |
Approved |
0.787 |
Intermediate Similarity |
NPD2532 |
Approved |
0.787 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7814 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7742 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7688 |
Intermediate Similarity |
NPD3226 |
Approved |
0.765 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7644 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7596 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7574 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7571 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7545 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.75 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7471 |
Intermediate Similarity |
NPD920 |
Approved |
0.7456 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7427 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7412 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD943 |
Approved |
0.7407 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7398 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7379 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7356 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7322 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7277 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD37 |
Approved |
0.7243 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7241 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7238 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7175 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD7228 |
Approved |
0.716 |
Intermediate Similarity |
NPD447 |
Suspended |
0.716 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7159 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7066 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD2491 |
Approved |
0.7065 |
Intermediate Similarity |
NPD3057 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7031 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7031 |
Intermediate Similarity |
NPD8313 |
Approved |
0.703 |
Intermediate Similarity |
NPD7698 |
Approved |
0.703 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7024 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD2163 |
Approved |
0.6984 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD2972 |
Approved |
0.698 |
Remote Similarity |
NPD3448 |
Approved |
0.698 |
Remote Similarity |
NPD3533 |
Approved |
0.6979 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6976 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.697 |
Remote Similarity |
NPD6534 |
Approved |
0.697 |
Remote Similarity |
NPD6535 |
Approved |
0.6966 |
Remote Similarity |
NPD5401 |
Approved |
0.6952 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.694 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.694 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD4287 |
Approved |
0.6931 |
Remote Similarity |
NPD2493 |
Approved |
0.6931 |
Remote Similarity |
NPD2494 |
Approved |
0.6928 |
Remote Similarity |
NPD6696 |
Suspended |
0.6927 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD7874 |
Approved |
0.6901 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD1613 |
Approved |
0.6897 |
Remote Similarity |
NPD5404 |
Approved |
0.6897 |
Remote Similarity |
NPD5406 |
Approved |
0.6897 |
Remote Similarity |
NPD5405 |
Approved |
0.6897 |
Remote Similarity |
NPD5408 |
Approved |
0.6893 |
Remote Similarity |
NPD6190 |
Approved |
0.6882 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6878 |
Remote Similarity |
NPD7048 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7801 |
Approved |
0.6875 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6872 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6866 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD1653 |
Approved |
0.6847 |
Remote Similarity |
NPD3450 |
Approved |
0.6847 |
Remote Similarity |
NPD3452 |
Approved |
0.6836 |
Remote Similarity |
NPD7003 |
Approved |
0.6829 |
Remote Similarity |
NPD4582 |
Approved |
0.6829 |
Remote Similarity |
NPD4583 |
Approved |
0.6824 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6814 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6813 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD2296 |
Approved |
0.6805 |
Remote Similarity |
NPD9494 |
Approved |
0.6798 |
Remote Similarity |
NPD4107 |
Approved |
0.6794 |
Remote Similarity |
NPD5676 |
Approved |
0.6786 |
Remote Similarity |
NPD1470 |
Approved |
0.6784 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD4004 |
Approved |
0.678 |
Remote Similarity |
NPD4002 |
Approved |
0.6769 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD4749 |
Approved |
0.6761 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD7240 |
Approved |
0.6753 |
Remote Similarity |
NPD6764 |
Approved |
0.6753 |
Remote Similarity |
NPD6765 |
Approved |
0.6742 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6734
|
Remote Similarity |
NPD2490 |
Approved |